Aschers modulates inflammation and amino acid metabolism by inhibiting the NF-κB, MAPK, JAK-STAT, PI3K-Akt, and AMPK pathways, thereby alleviating BPH in rats (22). Here, AKT1 is linked to benign prostatic hyperplasia.